http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102006050026-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf0562729156854042fb9fa5dbcfa86b |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 |
filingDate | 2006-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c5bd619267fd6fbe3601956d3045484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f25510628d129faa1087d113e3bfe1a2 |
publicationDate | 2008-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | DE-102006050026-A1 |
titleOfInvention | Use of compounds and pharmaceutical composition for suppression of the immune system |
abstract | The invention relates to the use of compounds of general formula (I), wherein R 1 is a branched or unbranched alkyl, alkenyl, cycloalkyl, alkoxyalkyl, alkoxycarbonylalkyl or aryl radical, R 2 is -H, a branched or unbranched alkyl, alkenyl, cycloalkyl, alkoxyalkyl, alkoxycarbonylalkyl or aryl radical, R3 is -OH and R4 is -H or R3 -H and R4 is -OH for the suppression of the immune system and pharmaceutical compositions containing at least one compound of the general formula (I) for the suppression of the immune system. In particular, the invention relates to the use of compounds of the general formula (I) and to pharmaceutical compositions comprising at least one compound of the general formula (I) for the prophylaxis and / or treatment of inflammatory conditions and / or inflammatory diseases, of conditions and / or diseases which are associated with an overreaction of the immune system, rejection reactions after transplantation and autoimmune diseases. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023083850-A1 |
priorityDate | 2006-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 225.